Clinical use of urine PCA3 mRNA testing
Increased sensitivity and specificity of urine prostate cancer assays can aid earlier detection and risk assessment
Publish date: September 1, 2009
Scott B. Shappell, MD, PhD , Leonard S. Marks, MD
Scott B. Shappell, MD, PhD , Leonard S. Marks, MD
Discovery of the prostate carcinoma-specific gene has led to the development of a promising urine-based laboratory test for the disease.